×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
HCAT – health catalyst, inc - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
HCAT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
07:22 am
hcat
Black Book Market Research Releases Global Survey Findings on Population Health Applications in Emerging Markets [Yahoo! Finance]
High
Report
Black Book Market Research Releases Global Survey Findings on Population Health Applications in Emerging Markets [Yahoo! Finance]
12/12
09:25 am
hcat
Tuva Health Launches Open-Source Platform to Transform Healthcare Analytics Industry [Yahoo! Finance]
Low
Report
Tuva Health Launches Open-Source Platform to Transform Healthcare Analytics Industry [Yahoo! Finance]
12/10
09:15 am
hcat
AllClear ID Welcomes Dale Sanders to Board of Directors
Medium
Report
AllClear ID Welcomes Dale Sanders to Board of Directors
12/10
08:05 am
hcat
Health Catalyst to Participate in Upcoming Investor Conference
Low
Report
Health Catalyst to Participate in Upcoming Investor Conference
12/4
07:26 am
hcat
Earnings To Watch: Domo (DOMO) Reports Q3 Results Tomorrow [Yahoo! Finance]
Low
Report
Earnings To Watch: Domo (DOMO) Reports Q3 Results Tomorrow [Yahoo! Finance]
12/4
07:26 am
hcat
What To Expect From Samsara's (IOT) Q3 Earnings [Yahoo! Finance]
Low
Report
What To Expect From Samsara's (IOT) Q3 Earnings [Yahoo! Finance]
12/3
04:26 pm
hcat
Ryan Smith Named as Chief Digital and Information Officer at Intermountain Health [Yahoo! Finance]
Low
Report
Ryan Smith Named as Chief Digital and Information Officer at Intermountain Health [Yahoo! Finance]
11/26
08:08 am
hcat
Health Catalyst, Inc. (NASDAQ: HCAT) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $12.00 price target on the stock, up previously from $11.00.
Neutral
Report
Health Catalyst, Inc. (NASDAQ: HCAT) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $12.00 price target on the stock, up previously from $11.00.
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2024
04:03 pm
hcat
health catalyst, inc - common stock
BEAT
Report
7.4%
health catalyst, inc - common stock
8/7/2024
04:13 pm
hcat
health catalyst, inc - common stock
MISS
Report
33.9%
health catalyst, inc - common stock
5/9/2024
04:03 pm
hcat
health catalyst, inc - common stock
BEAT
Report
-3.9%
health catalyst, inc - common stock
2/22/2024
04:03 pm
hcat
health catalyst, inc - common stock
BEAT
Report
-8.1%
health catalyst, inc - common stock
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/18
05:01 pm
hcat
Form 4 Health Catalyst, Inc. For: Dec 16 Filed by: Llewelyn Linda
Medium
Report
Form 4 Health Catalyst, Inc. For: Dec 16 Filed by: Llewelyn Linda
12/16
04:34 pm
hcat
Form 144 Health Catalyst, Inc. Filed by: Llewelyn Linda
Low
Report
Form 144 Health Catalyst, Inc. Filed by: Llewelyn Linda
12/10
05:05 pm
hcat
Form 4 Health Catalyst, Inc. For: Dec 06 Filed by: Landry Benjamin
Low
Report
Form 4 Health Catalyst, Inc. For: Dec 06 Filed by: Landry Benjamin
12/10
05:05 pm
hcat
Form 4 Health Catalyst, Inc. For: Dec 06 Filed by: Alger Jason
Low
Report
Form 4 Health Catalyst, Inc. For: Dec 06 Filed by: Alger Jason
12/6
04:52 pm
hcat
Form 4 Health Catalyst, Inc. For: Dec 04 Filed by: LeSueur Daniel
Medium
Report
Form 4 Health Catalyst, Inc. For: Dec 04 Filed by: LeSueur Daniel
12/6
04:30 pm
hcat
Form 144 Health Catalyst, Inc. Filed by: Alger Jason
Medium
Report
Form 144 Health Catalyst, Inc. Filed by: Alger Jason
12/6
04:30 pm
hcat
Form 144 Health Catalyst, Inc. Filed by: Landry Benjamin
Medium
Report
Form 144 Health Catalyst, Inc. Filed by: Landry Benjamin
12/4
07:00 pm
hcat
Form 4 Health Catalyst, Inc. For: Dec 01 Filed by: Hoggard Green Jill
Medium
Report
Form 4 Health Catalyst, Inc. For: Dec 01 Filed by: Hoggard Green Jill
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/24
Health Catalyst Expands COVID-19 Response Support and Provides Infrastructure to Enable Readiness for Future Demands
14.1%
12/19 Health Catalyst (NASDAQ: HCAT) is now covered by analysts at Raymond James. They set a "strong-buy" rating on the stock. 11.7%
2/27 Q4/2019 12/31/2019 EPS -0.210 ZacksConsensus -0.280 ActVsEst 0.070 - Beat 9.7%
3/17 Health Catalyst Plans to Support Health System Clients' COVID-19 Response with Three Initial Solutions Focused on Patient Tracking, Public Health Surveillance and Staff Augmentation Support 8.1%
10/29 Health Catalyst (NASDAQ: HCAT) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock. 7.6%
4/3 Form 4 Health Catalyst, Inc. For: Apr 01 Filed by: Sanders Dale 7.6%
3/3 Form 4 Health Catalyst, Inc. For: Feb 28 Filed by: Dixon Michael Edward 6.8%
8/8 Health Catalyst to Announce Second Quarter 2019 Operating Results and Host Conference Call on Thursday, August 22, 2019 6.0%
11/12 Q3/2019 9/30/2019 EPS -0.270 ZacksConsensus -0.370 ActVsEst 0.100 - Beat 5.4%
11/19 Steward Health Care Chooses Health Catalyst for Data-Driven Patient Care Expansion 5.0%
12/19 Health Catalyst (NASDAQ: HCAT) is now covered by analysts at Raymond James. They set a "strong-buy" rating on the stock. 11.7%
2/27 Q4/2019 12/31/2019 EPS -0.210 ZacksConsensus -0.280 ActVsEst 0.070 - Beat 9.7%
3/17 Health Catalyst Plans to Support Health System Clients' COVID-19 Response with Three Initial Solutions Focused on Patient Tracking, Public Health Surveillance and Staff Augmentation Support 8.1%
10/29 Health Catalyst (NASDAQ: HCAT) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock. 7.6%
4/3 Form 4 Health Catalyst, Inc. For: Apr 01 Filed by: Sanders Dale 7.6%
3/3 Form 4 Health Catalyst, Inc. For: Feb 28 Filed by: Dixon Michael Edward 6.8%
8/8 Health Catalyst to Announce Second Quarter 2019 Operating Results and Host Conference Call on Thursday, August 22, 2019 6.0%
11/12 Q3/2019 9/30/2019 EPS -0.270 ZacksConsensus -0.370 ActVsEst 0.100 - Beat 5.4%
11/19 Steward Health Care Chooses Health Catalyst for Data-Driven Patient Care Expansion 5.0%
TOP News Decliners
4/8
Health Catalyst, Inc. Announces Proposed Offering of $175 Million Convertible Senior Notes
-10.4%
8/23 Form 10-Q Health Catalyst, Inc. For: Jun 30 -10.2%
4/29 Form 4 Health Catalyst, Inc. For: Apr 28 Filed by: Sanders Dale -4.9%
2/20 Form 4 Health Catalyst, Inc. For: Feb 14 Filed by: Bullock D Fraser -4.3%
10/22 Health Catalyst (NASDAQ: HCAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $32.00 price target on the stock. -3.1%
12/9 Health Catalyst (NASDAQ: HCAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $46.00 price target on the stock. -3.0%
4/15 Form 4 Health Catalyst, Inc. For: Apr 13 Filed by: Dixon Michael Edward -2.9%
2/11 Form 4 Health Catalyst, Inc. For: Feb 07 Filed by: Larson-Green Julie -2.7%
4/14 Health Catalyst and Carle Health Partner to Improve Patient Care with Data and Analytics Solutions -2.6%
7/31 Health Catalyst-Using Analytics As A Catalyst For Better Healthcare Results [Seeking Alpha] -2.5%
8/23 Form 10-Q Health Catalyst, Inc. For: Jun 30 -10.2%
4/29 Form 4 Health Catalyst, Inc. For: Apr 28 Filed by: Sanders Dale -4.9%
2/20 Form 4 Health Catalyst, Inc. For: Feb 14 Filed by: Bullock D Fraser -4.3%
10/22 Health Catalyst (NASDAQ: HCAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $32.00 price target on the stock. -3.1%
12/9 Health Catalyst (NASDAQ: HCAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $46.00 price target on the stock. -3.0%
4/15 Form 4 Health Catalyst, Inc. For: Apr 13 Filed by: Dixon Michael Edward -2.9%
2/11 Form 4 Health Catalyst, Inc. For: Feb 07 Filed by: Larson-Green Julie -2.7%
4/14 Health Catalyst and Carle Health Partner to Improve Patient Care with Data and Analytics Solutions -2.6%
7/31 Health Catalyst-Using Analytics As A Catalyst For Better Healthcare Results [Seeking Alpha] -2.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: